Total Post-thyroidectomy Hypocalcemia After Preoperative Cholecalciferol Supplementation
Launched by HÔPITAL NOVO · Feb 26, 2021
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is investigating whether taking vitamin D3 (also known as cholecalciferol) before having total thyroid surgery can help prevent low calcium levels (hypocalcemia) after the operation. Low calcium levels can be a common issue after this type of surgery, and the researchers want to see if vitamin D3 can make a difference in keeping calcium levels stable.
To be eligible for this study, you need to be at least 18 years old and scheduled for a total thyroidectomy, which is the complete removal of the thyroid gland. You should also have a health insurance plan that covers you. However, you won't be able to participate if you've had similar surgeries before, have certain health conditions like severe kidney or liver problems, or have taken vitamin D supplements in the last three months. If you decide to join, you will receive more information and will need to give your consent before starting. Overall, this trial aims to improve patient care by exploring new ways to manage calcium levels after surgery.
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Patient ≥ 18 years old
- • Patient shall be operated on for a total thyroidectomy in one time for any indication
- • Written informed consent (IC) obtained
- • Patients with affiliation to the social security system
- Exclusion Criteria:
- • • Medical history of : Thyroid or parathyroid surgery Hyperparathyroidism Granulomatosis flare-up
- • Hypocalcemia, hypercalcemia/ hypercalciuria, or symptom of Hypocalcemia, hypercalcemia/ hypercalciuria, not due to thyroid pathologies
- • Chronic kidney disease grade ≥4
- • Severe liver failure
- • 25OHD supplementation within last 3 months before surgery
- • Malabsorption syndrome
- • Known hypersensitivity to vitamin D
- • Medical history of calcic lithiasis
- • Pregnant women
- • Vulnerable populations (guardianship or trusteeship)
- • Allergies to one of the components of the fruit juice
About Hôpital Novo
Hôpital Novo is a leading clinical trial sponsor dedicated to advancing medical research and improving patient outcomes through innovative studies and rigorous scientific methodologies. With a strong emphasis on collaboration and ethical practices, Hôpital Novo partners with healthcare professionals and institutions to conduct high-quality clinical trials across various therapeutic areas. Their commitment to patient safety, data integrity, and regulatory compliance ensures that all research initiatives are conducted to the highest standards, ultimately contributing to the development of new treatments and therapies that enhance healthcare delivery.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Paris, , France
Poissy, , France
Pontoise, , France
Auxerre, , France
Corbeil Essonnes, , France
La Roche Sur Yon, , France
Patients applied
Trial Officials
Dr Khaled AL TABAA
Principal Investigator
Hôpital NOVO
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials